2009 Press Releases
United States Announces Additional $120 Million for ARVs in South Africa
December 1, 2009
Pretoria Ambassador Donald H. Gips will announce that the United States will provide an addition $120 million (approximately R900 million) over two years for anti-retroviral (ARV) drugs. This one-time extra funding to procure ARVs will help ensure that there are adequate stocks on hand to meet the growing demand for ARVs in South Africa. This funding is over and above the R4.2 billion budgeted for the regular U.S. government contribution to the fight against HIV/AIDS in South Africa (2010 fiscal year). It will assist the Department of Health and provincial governments to meet their goals for antiretroviral treatments and to help build capacity in the provinces for planning and forecasting ARV needs. The additional funding is in direct response to a request from President Jacob Zuma.
Through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), the US has made the largest commitment in history by a single nation to combat a disease. The American people have provided more than $25 billion to the fight against global AIDS. In South Africa, PEPFAR support from 2004-2009 has totaled over R10 billion.
“This additional funding is in direct response to the Government of South Africa’s request,” noted Ambassador Gips. “The United States has a remarkable relationship with South Africa in the fight against HIV/AIDs, and South Africa has made significant and real strides in testing and counseling citizens about receiving treatment. This funding provides a bridge to help individual South Africans gain access to ARVs. We are pleased and honored to respond to President Zuma as South Africa’s partner in this fight.”